About Filisia
Filisia is a company based in London (United Kingdom) founded in 2014 by Georgios Papadakis. It operates as a SaaS and D2C. Filisia has raised $258.19 thousand across 2 funding rounds from investors including European Union and Deepbridge Capital. Filisia offers products and services including Cosmo, Cosmo Explore, Cosmo Excel, Cosmo Home, and Cosmo Pro. Filisia operates in a competitive market with competitors including MicroHealth, Twill, BioSymetrics, Cardio Renal and Theratrak, among others.
- Headquarter London, United Kingdom
- Founders Georgios Papadakis
-
Sectors
TechnologyEducation
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Filisia Interfaces Ltd
- Date of Incorporation 02 Jun, 2014
- Jurisdiction LONDON
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$258.19 K (USD)
in 2 rounds
-
Latest Funding Round
$258.19 K (USD), Seed
Apr 29, 2019
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Filisia
Filisia offers a comprehensive portfolio of products and services, including Cosmo, Cosmo Explore, Cosmo Excel, Cosmo Home, and Cosmo Pro.
Interactive tool for inclusive learning and therapy for people with disabilities
Exploratory application for learning needs and play activities
Advanced therapy-focused platform for cognitive development
Home-based inclusive tools for daily learning and therapy
Subscription for advanced therapy and educational features
People of Filisia
Unlock access to complete
Funding Insights of Filisia
Filisia has successfully raised a total of $258.19K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $258.19 thousand completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Filisia
Filisia has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and Deepbridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deepbridge Capital is focused on tax-efficient investment opportunities.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Filisia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Filisia
Investment portfolio details for Filisia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Filisia
Detailed financials for Filisia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Filisia Comparisons
Peer comparison for Filisia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Filisia
Filisia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MicroHealth, Twill, BioSymetrics, Cardio Renal and Theratrak, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Population health management and care coordination solutions are provided.
|
|
| Locked | Locked | Locked |
Evidence-based digital therapeutics and wellness apps for healthcare are provided.
|
|
| Locked | Locked | Locked |
Provider of a cognitive computing-based biomedical intelligence platform
|
|
| Locked | Locked | Locked |
Digital therapeutics for chronic kidney disease management are provided.
|
|
| Locked | Locked | Locked |
Provider of the app for physical therapists
|
Detailed competitors of Filisia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Filisia
Complete news archive for Filisia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Filisia
Filisia was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Filisia is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Georgios Papadakis is the current CEO of Filisia. They have also founded this company.
Filisia is a funded company, having raised a total of $258.19K across 2 funding rounds to date.
Cosmo, developed by Filisia, focuses on re-imagining inclusive education and therapy through interactive tools for people with learning disabilities, autism, and other conditions. It combines evidence-based approaches for learning, play, and rehabilitation, accessible via subscriptions or purchases. Based in London, United Kingdom, it serves users with special needs, including those with cerebral palsy or Down syndrome, emphasizing accessibility and impact through digital platforms.
Filisia's top competitors include BioSymetrics, Twill and MicroHealth.
Filisia offers Cosmo, Cosmo Explore, Cosmo Excel, Cosmo Home, and Cosmo Pro.
Filisia has 2 investors. Key investors include European Union, and Deepbridge Capital.